Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 20/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL389488 | 0.83 | GPR119 (0.70) | GPR119CYP2C9KCNH2 | |
| SCHEMBL390195 | 0.81 | GPR119 (0.68) | GPR119CYP2C9KCNH2 | |
| SCHEMBL5603764 | 0.77 | GPR119 (0.62) | GPR119CYP2C9KCNH2 | |
| SCHEMBL389690 | 0.77 | GPR119 (1.00) | GPR119CYP2C9KCNH2 | |
| SCHEMBL288589 | 0.77 | GPR119 (0.80) | GPR119CYP2C9KCNH2 | |
| SCHEMBL391161 | 0.76 | GPR119 (0.83) | GPR119CYP2C9KCNH2 | |
| SCHEMBL389389 | 0.76 | GPR119 (0.80) | GPR119CYP2C9KCNH2 | |
| SCHEMBL386088 | 0.75 | GPR119 (0.91) | GPR119CYP2C9KCNH2 | |
| SCHEMBL386082 | 0.75 | GPR119 (1.00) | GPR119CYP2C9KCNH2 | |
| SCHEMBL4462465 | 0.75 | GPR119 (0.69) | GPR119CYP2C9KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1808168-A1 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | Arena Pharmaceuticals, Inc. (US) | 2007-07-18 | — | — | EP | disclosed |